The role of Th17 cells in anti-cancer immunity;Znaczenie limfocytów Th17 w odporności przeciwnowotworowej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 244-250

  Hus, Iwona ^a   Macia̧g, Ewa ^b   Roliński, Jacek ^c  

^a Medical University of Lublin Klinika Hematoonkologii i Transplantacji Szpiku AM w Lublinie   (Poland)

^b Centrum Onkologii   (Poland)

^c NONE   (Poland)

Author keywords

Anti tumor response; Interleukin 17; T regulatory cells; Th17 cells

Indexed keywords

INTERLEUKIN 17;

ANIMAL; CD4+ T LYMPHOCYTE; HUMAN; IMMUNOLOGY; NEOPLASM; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-17; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 77954728888     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Acosta-Rodriguez E. V., Napolitani G., Lanzavecchia A., Sallusto F.: Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-βroducing human T helper cells. Nat. Immunol., 2007;8:942-949 (Pubitemid 47300008)
2. Alexandrakis M. G., Pappa C. A., Miyakis S., Sfiridaki A., Kafousi M., Alegakis A., Stathopoulos E. N.: Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. Eur. J. Intern. Med., 2006;17:412-416 (Pubitemid 44572138)
3. Arican O., Aral M., Sasmaz S., Ciragil P.: Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Infamm., 2005;5:273-279 (Pubitemid 41577417)
4. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautès-Fridman C., Fossiez F., Haicheur N., Fridman W. H., Tartour E.: Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood, 2002;99:2114-2121 (Pubitemid 34525496)
5. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., Höpner S., Centonze D., Bernardi G., DellAcqua M. L., Rossini P. M., Battistini L., Rötzschke O., Falk K.: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 110:1225-1232
6. Bryant V. L., Ma C. S., Avery D. T., Li Y., Good K. L., Corcoran L. M., de Waal Malefyt R., Tangye S. G.: Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol., 2007;179:8180-8190
7. Bullens D. M., Truyen E., Coteur L., Dilissen E., Hellings P. W., Dupont L. J., Ceuppens J. L.: IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res., 2006;7:135
8. Chen Z., Tato C. M., Muul L., Laurence A., O'Shea J. J.: Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum., 2007;56:2936-2946 (Pubitemid 47502740)
9. Chung Y., Chang S. H., Martinez G. J., Yang X. O., Nurieva R., Kang H. S., Ma L., Watowich S. S., Jetten A. M., Tian Q., Dong C: Critical regulation of early Th17 cell differentiation by interleukin-1 signalling. Immunity, 2009;30:576-587
10. Cirée A., Michel L., Camilleri-Bröet S., Jean Louis F., Oster M., Flageul B., Senet P., Fossiez F., Fridman W. H., Bachelez H., Tartour E.: Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int. J. Cancer, 2004;112:113-120 (Pubitemid 39249498)
11. Coombes J. L., Siddiqui K. R., Arancibia-Cárcamo C. V., Hall J., Sun C. M., Belkaid Y., Powrie F.: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β andretinoic acid-dependent mechanism. J. Exp. Med., 204:1757-1764
12. Cosmi L., De Palma R., Santarlasci V., Maggi L., Capone M., Frosali F., Rodolico G., Querci V., Abbate G., Angeli R., Berrino L., Fambrini M., Caproni M., Tonelli F., Lazzeri E., Parronchi P., Liotta F., Maggi E., Romagnani S., Annunziato F.: Human interleukin 17-βroducing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med., 2008;205:1903-1916
13. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med., 204:1257-1265
14. Dhodapkar K. M., Barbuto S., Matthews P., Kukreja A., Mazumder A., Vesole D., Jagannath S., Dhodapkar M. V.: Dendritic cells mediate the induction of polyfunctional human IL17-βroducing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood, 2008;112:2878-2885
15. Diveu C., McGeachy M. J., Boniface K., Stumhofer J. S., Sathe M., Joyce-Shaikh B., Chen Y., Tato C. M., McClanahan T. K., de Waal Malefyt R., Hunter C. A., Cua D. J., Kastelein R. A.: IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol., 2009;182:5748-5756
16. Harrington L. E., Hatton R. D., Mangan P. R., Turner H., Murphy T. L., Murphy K. M., Weaver C. T.: Interleukin 17-βroducing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol., 2005;6:1123-1132 (Pubitemid 41541790)
17. Hirahara N., Nio Y., Sasaki S., Minari Y., Takamura M., Iguchi C., Dong M., Yamasawa K., Tamura K.: Inoculation of human interleukin-17 gene-transfected Meth-A fibroosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology, 2001;61:79-89 (Pubitemid 32727592)
18. Hirahara N., Nio Y., Sasaki S., Takamura M., Iguchi C., Dong M., Yamasawa K., Itakura M., Tamura K.: Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Res., 2000;20:3137-3142
19. Horlock C., Stott B., Dyson P. J., Morishita M., Coombes R. C., Savage P., Stebbing J.: The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. Br. J. Cancer, 2009;100:1061-1067
20. Hu J., Yuan X., Belladonna M. L., Ong J. M., Wachsmann-Hogiu S., Farkas D. L., Black K. L., Yu J. S.: Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Cancer Res., 2006;66:8887-8896 (Pubitemid 44449207)
21. Kang S. G., Lim H. W., Andrisani O. M., Broxmeyer H. E., Kim C. H.: Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol., 2007;179:3724-3733
22. Kimura A., Naka T., Kishimoto T.: IL-6-dependent and-independent pathways in the development of interleukin 17-βroducing T helper cells. Proc. Natl. Acad. Sci. USA, 2007;104:12099-12104 (Pubitemid 47185636)
23. H17 cells. Nature, 2007;448:484-487 (Pubitemid 47123515)
24. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M. T., Martin T. J., Suda T.: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest., 1999;103:1345-1352 (Pubitemid 29218305)
25. Kottke T., Sanchez-Perez L., Diaz R. M., Thompson J., Chong H., Harrington K., Calderwood S. K., Pulido J., Georgopoulos N., Selby P., Melcher A., Vile R.: Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res., 2007;67:11970-11979
26. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., Huang E., Finlayson E., Simeone D., Welling T. H., Chang A., Coukos G., Liu R., Zou W.: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood, 2009;114:1141-1149
27. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W.: Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood, 2009;114:357-359
28. Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., Chang A., Zou W.: Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol., 2007;178:6730-6733 (Pubitemid 46847396)
29. Kuang D. M., Peng C., Zhao Q., Wu Y., Chen M. S., Zheng L.: Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology, 2010;51:154-164
30. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., Takabayashi K., Iwamoto I.: Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 2000;43:2455-2463
31. Langowski J. L., Kastelein R. A., Oft M.: Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol., 2007;28:207-212 (Pubitemid 46654872)
32. Langowski J. L., Zhang X., Wu L., Mattson J. D., Chen T., Smith K., Basham B., McClanahan T., Kastelein R. A., Oft M.: IL-23 promotes tumour incidence and growth. Nature 2006;442:461-465 (Pubitemid 44264796)
33. Martinez G. J., Nurieva R. I., Yang X. O., Dong C: Regulation and function of proinflammatory TH17 cells. Ann. N. Y Acad. Sci., 2008;1143:188-211
34. Martin-Orozco N., Muranski P., Chung Y., Yang X. O., Yamazaki T., Lu S., Hwu P., Restifo N. P., Overwijk W. W., Dong C: T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 2009;31:787-798
35. Miyahara Y., Odunsi K., Chen W., Peng G., Matsuzaki J., Wang R. F.: Generation and regulation of human CD4+IL-17-βroducing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA, 2008;105:15505-11550
36. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L.: Two types of murine helper T cell clone. I. Defnition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 1986;136:2348-2357 (Pubitemid 16136806)
37. Muranski P., Boni A., Antony P. A., Cassard L., Irvine K. R., Kaiser A., Paulos C. M., Palmer D. C., Touloukian C. E., Ptak K., Gattinoni L., Wrzesinski C., Hinrichs C. S., Kerstann K. W., Feigenbaum L., Chan C. C., Restifo N. P.: Tumor-specific Th17-βolarized cells eradicate large established melanoma. Blood, 2008;112:362-373
38. Numasaki M., Fukushi J., Ono M., Narula S. K., Zavodny P. J., Kudo T., Robbins P. D., Tahara H., Lotze M. T.: Interleukin-17 promotes angiogenesis and tumor growth. Blood, 2003;101:2620-2627 (Pubitemid 36857622)
39. Numasaki M., Watanabe M., Suzuki T., Takahashi H., Nakamura A., McAllister F., Hishinuma T., Goto J., Lotze M. T., Kolls J. K., Sasaki H.: IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol., 2005;175:6177-6189 (Pubitemid 41508106)
40. Nurieva R., Yang X. O., Martinez G., Zhang Y., Panopoulos A. D., Ma L., Schluns K., Tian Q., Watowich S. S., Jetten A. M., Dong C: Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature., 2007;448:480-483 (Pubitemid 47123514)
41. Oehler-Jänne C., Huguet F., Provencher S., Seifert B., Negretti L., Riener M. O., Bonet M., Allal A. S., Ciernik I. F.: HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-βositive patients receiving highly active antiretroviral therapy. J. Clin. Oncol., 2008;26:2550-2557
42. Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y. H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C: A distinct lineage of CD4 T cells regulates tissue infammation by producing interleukin 17. Nat Immunol., 2005;6:1133-1141 (Pubitemid 41541791)
43. Radhakrishnan S., Cabrera R., Schenk E. L., Nava-Parada P., Bell M. P, Van Keulen V. P., Marler R. J., Felts S. J., Pease L. R.: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J. Immunol.: 2008;181:3137-3147
44. Romagnani S.: Human Th17 cells. Arthritis Res. Ther., 2008;10:206-213
45. Sfanos K. S., Bruno T. C., Maris C. H., Xu L., Thoburn C. J., DeMarzo A. M., Meeker A. K., Isaacs W. B., Drake C. G.: Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res., 2008;14:3254-3261
46. Sun C. M., Hall J. A, Blank R. B., Bouladoux N., Oukka M., Mora J. R, Belkaid Y.: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med., 204:1775-1785
47. Taams L. S., van Amelsfort J. M., Tiemessen M. M., Jacobs K. M., de Jong E. C, Akbar A. N., Bijlsma J. W., Lafeber F. P.: Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol., 2005;66:222-230 (Pubitemid 40395242)
48. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., Sastre-Garau X., Couturier J., Mosseri V., Vives V., Banchereau J., Fridman W. H., Wijdenes J., Lebecque S., Sautès-Fridman C: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999;59:3698-3704 (Pubitemid 29381875)
49. Tiemessen M. M., Jagger A. L., Evans H. G., van Herwijnen M. J., John S., Taams L. S.: CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA, 2007;104:19446-19451
50. Wang L., Yi T., Kortylewski M., Pardoll D. M., Zeng D., Yu H.: IL-17 can promote tumor growth through an IL-6-Stat3 signalling pathway. J. Exp. Med., 2009;206:1457-1464
51. Wilson N. J., Boniface K., Chan J. R., McKenzie B. S., Blumenschein W. M., Mattson J. D., Basham B., Smith K., Chen T., Morel F., Lecron J. C, Kastelein R. A., Cua D. J., McClanahan T. K., Bowman E. P., de Waal Malefyt R.: Development cytokine profile and function of human interleukin 17-βroducing helper T cells. Nat Immunol., 2007;8:950-957 (Pubitemid 47300009)
52. Wong C. K., Ho C. Y., Li E. K., Lam C. W.: Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus, 2000;9:589-593
53. Xiao S., Jin H., Korn T., Liu S. M., Oukka M., Lim B., Kuchroo V. K.: Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol., 2008;181:2277-2284
54. Yamamoto M., Kamigaki T., Yamashita K.: Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer. Oncol. Rep., 2009;22:337-343
55. H17 cells. Nature, 2008;454:350-352
56. Yang X. O., Nurieva R., Martinez G. J., Kang H. S., Chung Y., Pappu B. P., Shah B., Chang S. H., Schluns K. S., Watowich S. S., Feng X. H., Jetten A. M., Dong C: Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity, 2008;29:44-56
57. Yao Z., Painter S. L., Fanslow W. C., Ulrich D., Macduff B. M., Spriggs M. K., Armitage R. J.: Human IL-17: a novel cytokine derived from T cells. J. Immunol., 1995;155:5483-5486
58. Zhang B., Rong G., Wei H., Zhang M., Bi J., Ma L., Xue X., Wei G., Liu X., Fang G.: The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun.: 2008;374:533-537
59. Zhang J. P., Yan J., Xu J., Pang X. H., Chen M. S., Li L., Wu C., Li S. P., Zheng L.: Increased intratumoral IL-17-βroducing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol., 2009;50:980-989
60. Zhou L., Ivanov I. I., Spolski R., Min R., Shenderov K., Egawa T., Levy D. E., Leonard W. J., Littman D. R.: IL-6 programs T (H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol., 2007;8:967-674
61. Zhou L., Lopes J. E., Chong M. M., Ivanov I. I., Min R., Victora G. D., Shen Y., Du J., Rubtsov Y. P., Rudensky A. Y., Ziegler S. F., Littman D. R.: TGF-β-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORgammat function. Nature, 2008;453:236-240 (Pubitemid 351667978)
62. Zhu J., Paul W. E.: CD4 T cells: fates, functions, and faults. Blood 2008;112:1557-1569